Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3689849016 | Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection (clinical drug) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 3689850016 | Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | en | Synonym | Inactive | Entire term case insensitive | SNOMED CT core module |
| 3689851017 | Octreotide (as octreotide acetate) 20 mg powder for suspension for injection vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Is a | Product containing octreotide | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Has manufactured dose form | Powder for conventional release suspension for injection | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Has presentation strength numerator unit | milligram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Has unit of presentation | Vial | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Has basis of strength substance | Octreotide | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Has presentation strength numerator value | 20 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Has precise active ingredient | Octreotide acetate | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely octreotide (as octreotide acetate) 20 milligram/1 vial powder for conventional release suspension for injection | Is a | Product containing only octreotide in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR